1. Home
  2. TFSL vs AXSM Comparison

TFSL vs AXSM Comparison

Compare TFSL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

HOLD

Current Price

$13.88

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$167.48

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFSL
AXSM
Founded
1938
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
9.0B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
TFSL
AXSM
Price
$13.88
$167.48
Analyst Decision
Strong Buy
Analyst Count
0
20
Target Price
N/A
$183.10
AVG Volume (30 Days)
701.0K
705.5K
Earning Date
01-29-2026
02-17-2026
Dividend Yield
8.14%
N/A
EPS Growth
14.29
N/A
EPS
0.32
N/A
Revenue
$318,974,000.00
$561,263,000.00
Revenue This Year
$11.17
$66.40
Revenue Next Year
$4.08
$56.13
P/E Ratio
$43.38
N/A
Revenue Growth
4.70
65.83
52 Week Low
$11.29
$79.19
52 Week High
$14.73
$184.40

Technical Indicators

Market Signals
Indicator
TFSL
AXSM
Relative Strength Index (RSI) 50.82 60.12
Support Level $13.21 $168.58
Resistance Level $13.92 $184.40
Average True Range (ATR) 0.28 6.75
MACD -0.03 1.26
Stochastic Oscillator 49.45 55.48

Price Performance

Historical Comparison
TFSL
AXSM

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: